Oncolytics Biotech Stock Forecast for 2023 - 2025 - 2030
Updated on 05/04/2024
Oncolytics Biotech Stock Forecast and Price Target
Oncolytics Biotech's most recent price target of C$7.25 for 2024 was provided by renowned analysts over the past few months, with an average prediction of C$7.25. If this prediction is correct, Oncolytics Biotech's stock could rise by 353.13 percent from its current trading price. The potential increase for the stock is C$7.25 per share, with a possible range of C$3.00 to C$9.00. If you are interested in ONC stock, it is important to also consider its competitors.
353.13% Upside
Oncolytics Biotech Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Oncolytics Biotech's Price has grown, increasing from C$0.00 to C$0.00 – an increase of 100.00%. For next year, the 6 analysts predict Fair Value of C$1.70, which would mean an increase of 100.00%. Over the next seven years, the pros' prediction is Fair Valueof C$2.91, which would mean a seven-year growth forecast of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BHC Stock Forecast | Bausch Health Companies | Hold |
15
|
$7.82 | Buy/Sell | $9.50 | 21.48% |
| TLRY Stock Forecast | Tilray Brands | Outperform |
6
|
$2.10 | Buy/Sell | $2.74 | 4.76% |
| BLU Stock Forecast | BELLUS Health | - |
6
|
C$19.48 | Buy/Sell | C$0.00 | -100.00% |
| CRON Stock Forecast | Cronos Group | Outperform |
6
|
C$3.64 | Buy/Sell | C$3.38 | -7.42% |
| JWEL Stock Forecast | Jamieson Wellness | Outperform |
18
|
C$25.87 | Buy/Sell | C$38.40 | 37.22% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| TSND Stock Forecast | TerrAscend | Buy |
12
|
C$2.40 | Buy/Sell | C$2.74 | 20.00% |
| ACB Stock Forecast | Aurora Cannabis | Outperform |
6
|
C$9.20 | Buy/Sell | C$1.06 | -13.04% |
| GUD Stock Forecast | Knight Therapeutics | Outperform |
14
|
C$5.91 | Buy/Sell | C$6.48 | 18.44% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| OGI Stock Forecast | Organigram Holdings | Outperform |
5
|
C$2.56 | Buy/Sell | C$3.31 | 46.48% |
| FIRE Stock Forecast | The Supreme Cannabis Company | - |
4
|
C$0.33 | Buy/Sell | C$0.00 | -100.00% |
| CPH Stock Forecast | Cipher Pharmaceuticals | Buy |
0
|
C$8.95 | Buy/Sell | C$5.45 | -10.61% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| HITI Stock Forecast | High Tide | Buy |
8
|
C$2.97 | Buy/Sell | C$5.85 | 102.02% |
| BHSC Stock Forecast | BioHarvest Sciences | - |
6
|
C$0.23 | Buy/Sell | C$0.00 | -100.00% |
| NGEN Stock Forecast | NervGen Pharma | Outperform |
4
|
C$2.33 | Buy/Sell | C$5.00 | 93.13% |
Oncolytics Biotech EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Oncolytics Biotech's EBITDA has grown by 32.87%, from C$-25.37M to C$-33.71M. For the next year, analysts are expecting EBITDA to reach C$-48.14M – an increase of 42.81%. By 2030, professionals believe that Oncolytics Biotech's EBITDA will decrease by 576.20%, reaching C$160.53M – a concerning trend for the company.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| HLS Stock Forecast | HLS Therapeutics | Outperform |
15
|
C$4.75 | Buy/Sell | C$6.07 | -24.63% |
| RX Stock Forecast | BioSyent | Outperform |
16
|
C$8.70 | Buy/Sell | C$8.00 | 3.45% |
| TH Stock Forecast | Theratechnologies | Outperform |
8
|
C$1.79 | Buy/Sell | C$8.00 | 237.43% |
Oncolytics Biotech EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Oncolytics Biotech's EBIT has grown from C$-25.46M to C$-33.79M – a 32.72% increase. Next year, analysts are expecting EBIT to reach C$-43.34M – an increase of 28.26%. In 2030, professionals predict that Oncolytics Biotech's EBIT will decrease by 866.62%, to C$259.04M.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| VLNS Stock Forecast | The Valens | - |
0
|
C$1.01 | Buy/Sell | C$2.36 | -100.00% |
| LOVE Stock Forecast | Cannara Biotech | - |
-12
|
C$0.93 | Buy/Sell | C$0.00 | -100.00% |
| CXXI Stock Forecast | C21 Investments | - |
0
|
C$0.55 | Buy/Sell | C$0.00 | -100.00% |
Oncolytics Biotech EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Oncolytics Biotech's EPS has grown, increasing from C$-0.64 to C$0.00 – an increase of 100.00%. For next year, the 6 analysts predict EPS of C$-0.52, which would mean an increase of 100.00%. Over the next seven years, the pros' prediction is EPSof C$3.00, which would mean a seven-year growth forecast of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| HEXO Stock Forecast | HEXO | - |
4
|
C$0.88 | Buy/Sell | C$0.00 | -100.00% |
| DB Stock Forecast | Decibel Cannabis | Buy |
0
|
C$0.12 | Buy/Sell | C$0.50 | 191.67% |
| SOL Stock Forecast | SOL Global Investments | - |
0
|
C$0.10 | Buy/Sell | C$0.00 | -100.00% |
.jpg)